"I think the line "*Encapsulated islet cells incorporate technology from Novocell, Inc. and SurModics" may be more telling."
Perhaps, but its so vague it could refer to the islet cell encapsulation per se rather than general cellular encapsulation with the technology they are using, the "CELLabration Cell Encapsulation System". SRDX's patents pertain to the use of crosslinkable macromers (including PEG) bearing initiator groups (UV activated) and polymerizable groups, which it is claimed has advantages over the use of seperate, low molecular weight initiators. They refer to this as a "crosslinkable macromer system". My guess is that this is SRDX's "CELLabration System".
Market Data 
Markets 
AI
